Cathie Wood's position in Veracyte is currently worth $216 Million. That's 1.49% of their equity portfolio (21st largest holding). The investor owns 11.55% of the outstanding Veracyte stock. The first Veracyte trade was made in Q4 2016. Since then Cathie Wood bought shares sixteen more times and sold shares on six occasions. The investor's estimated purchase price is $218 Million, resulting in a loss of 0.9%.